| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Change in fair value of warrant liability | -1,146 | -5,691 | ||
| Total other income (expense), net | 1,938 | 6,381 | ||
| Net loss and comprehensive loss | -11,269 | -4,796 | ||
| Earnings per share, basic | -0.21 | -0.09 | ||
| Earnings per share, diluted | -0.21 | -0.09 | ||
| Weighted average number of shares outstanding, basic | 54,894,347 | 51,489,929 | ||
| Weighted average number of shares outstanding, diluted | 54,894,347 | 51,489,929 | ||
Candel Therapeutics, Inc. (CADL)
Candel Therapeutics, Inc. (CADL)